New Leaders within UM
James S. Gammie, M.D., professor of surgery, has been appointed chief of the division of cardiac surgery. In his new role, he oversees an extensive range of cardiac surgical services, from repairing congenital heart defects in infants and children to heart transplantations and other complex procedures for high-risk adult patients.
Dr. Gammie, who has been a member of the University of Maryland faculty since 2002, is an expert in surgery of the mitral valve and a nationally known cardiac surgery outcomes investigator. He currently performs more than 200 mitral valve operations
per year. He has developed a
specialized practice focusing on mitral valve repair, minimally invasive mitral valve surgery and the surgical treatment of infective endocarditis. He has organized a clinical research unit within the division of cardiac surgery and serves as a principal investigator for the NHLBI-sponsored multi-center Cardiothoracic Surgery Trials Network.
Dr. Gammie is a highly published physician-scientist and serves in editorial roles for numerous cardiothoracic journals, including Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Circulation and the Journal of Heart Valve Disease.
Dr. Gammie received his A.B. in biochemistry at Brown University and his M.D. at the University of
Massachusetts Medical School. His clinical training was performed at the University of Pittsburgh Medical
School, where he completed his residency in general surgery, followed LISA SHULMAN, M.D. by a research fellowship within the divisions of cellular therapeutics and cardiothoracic surgery, and a clinical
fellowship within the division of cardiothoracic surgery.
Dr. Gammie can be reached at 410-328-5842.
Minesh P. Mehta, M.B.Ch.B., F.A.S.T.R.O., has been appointed as medical director of the Maryland Proton Treatment Center (opening in 2015), as well as professor and associate director of clinical research in the department of radiation oncology, University of Maryland School of Medicine. He comes to
Baltimore from Chicago where he was a professor and co-director of the Radiation Oncology Residency Training Program at Northwestern University.
While the Proton Center is built, Dr. Mehta will be seeing and treating brain tumor and lung cancer patients
within the Greenebaum Cancer Center. In his role as medical director, he will work in the development of
clinical trials and research protocols for patients, assume a leadership role within the evolving nationwide proton center consortium, as well as develop and integrate criteria for proton therapy patient selection within the department of radiation oncology’s clinical practice guidelines.
Dr. Mehta currently chairs the Brain Tumor Committee of the National Institutes of Health-funded Radiation Therapy Oncology Group focusing on innovative clinical trials for patients with various tumors of the central nervous system. He maintains an active interest in radiation-drug interactions, amelioration of radiation toxicities, incorporation of advanced radiation and imaging technologies, and is keenly interested in expanding the frontiers of personalized care in radiotherapy.
Dr. Mehta received his medical
degree with highest honors from the University of Zambia School of Medicine in Lusaka, Zambia. He completed his radiation oncology training at the University of Wisconsin, immediately joining the faculty at the university. He became professor and was chair of the department of human oncology at the University of Wisconsin for a decade from 1997-2007.
Dr. Mehta can be reached at 410-328-2325.
Zeljko Vujaskovic, M.D., Ph.D., has been appointed as professor and director of the new division of translational radiation sciences in the department of radiation oncology. He joins us from Duke
University, where he has been since 1999.
The new division of translational radiation sciences will serve to further expand and centralize cutting-edge
research in radiation biology, leading the exploration of new ways to treat and eradicate deadly cancers.
Dr. Vujaskovic is an accomplished National Institutes of Health-funded physician-scientist with outstanding
leadership skills and a distinguished career in research and patient care.